Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ERRγ agonist-1 can be used in neuropsychological disorders research. ERRγ agonist-1 increases the ERRγ transcriptional activities that is a potent agonist of ERRγ [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | ERRγ agonist-1 can be used in neuropsychological disorders research. ERRγ agonist-1 increases the ERRγ transcriptional activities that is a potent agonist of ERRγ [1]. |
In vitro | ERRγ agonist-1 (Compound 5d), at a concentration of 5 μM over three days, significantly enhances the expression of markers for dopaminergic neuron phenotype, namely tyrosine hydroxylase (TH) and dopamine transporter (DAT), in SH-SY5Y neuroblastoma cells [1]. This elevation in dopaminergic markers is attributed to ERRγ agonist-1's activation of the CREB-signaling pathway, leading to an induction of dopaminergic neuronal phenotypes. Western Blot analysis confirms the increased levels of TH and DAT in SH-SY5Y cells under these conditions [1]. |
Molecular Weight | 311.38 |
Formula | C17H21N5O |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ERRγ agonist-1 inhibitor inhibit